Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RELV

Reliv' International (RELV) Stock Price, News & Analysis

Reliv' International logo

About Reliv' International Stock (NASDAQ:RELV)

Advanced Chart

Key Stats

Today's Range
$2.58
$2.59
50-Day Range
$2.50
$3.73
52-Week Range
$2.50
$4.42
Volume
1,052 shs
Average Volume
23,200 shs
Market Capitalization
$4.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RELV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reliv' International and its competitors with MarketBeat's FREE daily newsletter.

RELV Stock News Headlines

RELV Reliv' International, Inc.
Reliv' International, Inc. (RELV)
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Agape ATP Corporation (ATPC)
North American Morning Briefing: Stocks Set for -2-
Reliance Naval and Engineering Ltd
RELV Real-Time Quotes
See More Headlines

RELV Stock Analysis - Frequently Asked Questions

Reliv' International, Inc. (NASDAQ:RELV) posted its earnings results on Friday, May, 15th. The company reported $0.38 earnings per share (EPS) for the quarter. The company earned $10.28 million during the quarter. Reliv' International had a negative net margin of 0.61% and a negative trailing twelve-month return on equity of 1.89%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Reliv' International investors own include Enterprise Products Partners (EPD), Aquestive Therapeutics (AQST), iBio (IBIO), Ocean Power Technologies (OPTT), Rigel Pharmaceuticals (RIGL), Sonoma Pharmaceuticals (SNOA) and Sunesis Pharmaceuticals (SNSS).

Company Calendar

Last Earnings
5/15/2020
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:RELV
CIK
768710
Fax
N/A
Employees
91
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$440 thousand
Net Margins
-0.61%
Pretax Margin
N/A
Return on Equity
-1.89%
Return on Assets
-1.31%

Debt

Debt-to-Equity Ratio
0.05
Current Ratio
1.70
Quick Ratio
1.04

Sales & Book Value

Annual Sales
$35.06 million
Price / Sales
0.13
Cash Flow
$0.06 per share
Price / Cash Flow
44.53
Book Value
$6.36 per share
Price / Book
0.41

Miscellaneous

Outstanding Shares
1,746,000
Free Float
N/A
Market Cap
$4.52 million
Optionable
Not Optionable
Beta
-0.10
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:RELV) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners